Taiwan FDA registration 5d8303bc5cd8a04f2a4e1fb8ec2b14e4

"Nova" Hemoglobin control solution (Non-Sterile)

TW: "露華" 血紅素品管液 (未滅菌)

Taiwan·Risk Class 1·MD·NOVA BIOMEDICAL CORPORATION·Registered Mar 02, 2018 – Mar 02, 2023Expired

Registration details

Analysis ID: 5d8303bc5cd8a04f2a4e1fb8ec2b14e4
License Form: Ministry of Health Medical Device Import No. 018852
Customs Code: DHA09401885205

Company information

Manufacturer: NOVA BIOMEDICAL CORPORATION
Manufacturer Country: United States
Authorized Representative: NOVA BIOMEDICAL TAIWAN CORP.

Product details

Intended Use: Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A1660 Quality Control Materials (Analytical and Non-Analytical)
Import Information: Imported from abroad

Dates and status

Registration Date: Mar 02, 2018
Expiry Date: Mar 02, 2023

About this record

Access comprehensive regulatory information for "Nova" Hemoglobin control solution (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 5d8303bc5cd8a04f2a4e1fb8ec2b14e4 and manufactured by NOVA BIOMEDICAL CORPORATION. The authorized representative in Taiwan is NOVA BIOMEDICAL TAIWAN CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.